New daily persistent headache: Clinical perspective

Headache

Volumn 51, Issue 4, 2011, Pages 641-649

  Rozen, Todd D ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Chronic daily headache; Joint hypermobility; New daily persistent headache; Tumor necrosis factor alpha

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; CYTOKINE; DOXYCYCLINE; GABAPENTIN; METHYLPREDNISOLONE; MEXILETINE; MINOCYCLINE; MONTELUKAST; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR; TETRACYCLINE DERIVATIVE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

CEREBROSPINAL FLUID LEVEL; CERVICAL SPINE; CHRONIC DAILY HEADACHE; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG OVERDOSE; HEAD INJURY; HEADACHE; HUMAN; JOINT HYPERMOBILITY; LIFE EVENT; LIFE STRESS; MIGRAINE; NAUSEA; NERVE BLOCK; NEW DAILY PERSISTENT HEADACHE; ONSET AGE; PATHOGENESIS; PHONOPHOBIA; PHOTOPHOBIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PRIMARY HEADACHE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE; SYMPTOM; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

BACTERIAL INFECTIONS; DIAGNOSIS, DIFFERENTIAL; HEADACHE DISORDERS; HUMANS; RISK FACTORS; VIRUS DISEASES;

EID: 79953699032     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01871.x     Document Type: Review

References (31)

1. Vanast WJ. New daily persistent headaches: Definition of a benign syndrome. Headache. 1986;26:317.
2. Silberstein SD, RB L. Chronic daily headache, including transformed migraine, chronic tension-type headache and medication overuse. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's Headache and Other Head Pain. Oxford: Oxford University Press; 2001:247-282.
3. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999;38:497-506.
4. Bigal ME, Sheftell FD, Rapoport AM, Lipton RB, Tepper SJ. Chronic daily headache in a tertiary care population: Correlation between the international headache society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia. 2002;22:432-438. (Pubitemid 36606062)
5. Koenig MA, Gladstein J,McCarter RJ, Hershey AD,Wasiewski W, the pediatric committee of the American Headache Society. Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache. 2002;42:491-500.
6. Meineri P, Torre E, Rota E, Grossa E. New daily persistent headache: Clinical and serological characteristics in a retrospective study. Neurol Sci. 2004;25(Suppl. 3):S281-S287.
7. Wang SJ, Fuh JL, Lu SR, Juang KD. Chronic daily headache in adolescents: Prevalence, impact, and medication overuse. Neurology. 2006;66:193-197.
8. Grande RB, Aaseth K, Lundqvist C, Russell MB. Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache. Cephalalgia. 2009;29:1149-1155.
9. Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22:66-69. (Pubitemid 34626027)
10. Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness drug based treatment prognosis new daily persistent headache: Thirty cases in Japan. Cephalagia. 2004;24:955-959. (Pubitemid 39471922)
11. Kung E, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. New daily persistent headache in a paediatric population. Cephalalgia. 2009;29:17-22.
12. Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010;74:1358-1364.
13. Diaz-Mitoma F, Vanast WJ, Tyrell DL. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet. 1987;1:411-415. (Pubitemid 17016581)
14. Santoni JR, Santoni-Williams CJ. Headache and painful lymphadenopathy in extracranial or systemic infection: Etiology of new daily persistent headaches. Intern Med. 1993;32:530-533.
15. Stewart WF, Scher AI, Lipton RB. Stressful life events and risk of chronic daily headache: Results from the frequent headache epidemiology study. Cephalalgia. 2001;21:278-280.
16. Mack K. What causes new daily persistent headache in children? Cephalalgia. 2003;23:609.
17. Rozen TD, Roth JM, Denenberg N. Joint hypermobility as a predisposing factor for the development of new daily persistent headache. Headache. 2005;45:828-829.
18. Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep. 2003;2:155-161.
19. Piovesan EJ, Kowacs PA, Tatsui CE, et al. Referred pain after painful stimulation of the greater occipital nerve in humans: Evidence of convergence of cervical afferences on trigeminal nuclei. Cephalalgia. 2001;21:107-109. (Pubitemid 32575473)
20. Rozen TD, Swidan Rozen TD, Swidan S. Elevation of CSF tumor necrosis factor alpha levels in NDPH and treatment refractory chronic daily migraine. Headache. 2006;46:897.
21. Olson JK, Girvin AM, Miller SD. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J Virol. 2001;75:9780-9789. (Pubitemid 32900113)
22. O'Conner KA, Johnson JD, Hansen MK, et al. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003;991:123-132. (Pubitemid 37297941)
23. Fu D, Guo Q, Ai Y, et al. Glial activation and segmental upregulation of interleukin-1β (IL-1β) in the rat spinal cord after surgical incision. Neurochem Res. 2006;31:333-340.
24. Calcitonin DPL. Gene-related peptide (CGRP) and migraine. Headache. 2006;46(suppl. 1):3-8.
25. Goadsby PJ, Boes C. New Daily persistent headache. J Neurol Neurosurg Psychiatry. 2002;72(suppl. II):ii6-ii9.
26. Marcelis J, Silberstein SD. Idiopathic intracranial hypertension without papilledema. Arch Neurol. 1991;48:392-399.
27. Rozen TD. Successful treatment of new daily persistent headache with gabapentin and topiramate. Headache. 2002;42:433.
28. Rozen TD. Doxycycline for treatment resistant new daily persistent headache. Neurology. 2008;70(Suppl. 1):A348.
29. Marmura MJ, Passero FC, Young WB. Mexiletine for refractory chronic daily headache: A report of nine cases. Headache. 2008;48:1506-1510.
30. Prakash S, Shah ND. Post-Infectious new daily persistent headache may respond to intravenous methylprednisolone. J Headache Pain. 2010;1:59-66.
31. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004;24(Suppl. 1):9-160.